Physician-scientist and drug discovery leader to guide next phase of translational medicine program ...

Saqib Islam, chief executive Officer of newly launched Beeline Medicines. The pace of private financing in biopharma steps up ...

Equipped with $300 million, Beeline has an oral medicine for the treatment of lupus as well as other experimental drugs ...

Leading Beeline Medicines’ pipeline is afimetoran, which is in Phase 2 development for systemic lupus erythematosus with data ...

The former leaders of SpringWorks Therapeutics are back with a new biotech venture that is already buzzing from a $300 ...

Beeline Medicines launches with $300 million from Bain Capital and five drug programs from Bristol Myers Squibb, including a ...

Plaintiff, a 45-year-old Asian woman who lives in Florida, sued her former employer, a biopharmaceutical company headquartered in Connecticut, contending she was terminated from her role as vice ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.

STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — SpringWorks Therapeutics Inc. (SWTX) on Friday reported a loss of $83.2 million in its first quarter. The Stamford, Connecticut-based company said it had ...

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) shares are trading higher on Monday after the company inked a deal to be acquired by Merck & Company, Inc. (NYSE:MRK) for $47 per share in cash. The ...